CSN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Oct 2025)
What this means for you
Registered since 29 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87833163
- Registration number
- 5898002
- Mark type
- Stylized text
- Filed
- 14 Mar 2018
- Published for opposition
- 31 Jul 2018
- Registered
- 29 Oct 2019
- Attorney of record
- JANET G RICCIUTI
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of remyelination, diseases of Multiple Sclerosis, and the treatment of cancer
Owner
- CLENE NANOMEDICINE, INC., SALT LAKE CITY, UT, US
- CLENE NANOMEDICINE, INC., SALT LAKE CITY, UT, US
- CLENE NANOMEDICINE, INC., SALT LAKE CITY, UT, US
Prosecution history
- 08 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 29 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 27 Sept 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Sept 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Sept 2019 — NON-FINAL ACTION E-MAILED
- 23 Sept 2019 — SU - NON-FINAL ACTION - WRITTEN
- 17 Sept 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Aug 2019 — USE AMENDMENT FILED
- 17 Sept 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Aug 2019 — TEAS STATEMENT OF USE RECEIVED